Abbott Vascular3200 Lakeside Drivesanta Clara Ca 95054 Pma Numberp110019 Supplement Numbers122 Date Received06 23 2022 Decision Date09 14 2022 Product Code Niq Advisory Committee Cardiovascular Supplement Typereal Time Process Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Abbott Vascular3200 Lakeside Drivesanta Clara Ca 95054 Pma Numberp110019 Supplement Numbers122 Date Received06 23 2022 Decision Date09 14 2022 Product Code Niq Advisory Committee Cardiovascular Supplement Typereal Time Process Supplement Reason Labeling Change Indications Instructions Shelf Life Tradename Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P110019S122 ABBOTT VASCULAR3200 Lakeside Drivesanta Clara, CA 95054 PMA NumberP110019 Supplement NumberS122 Date Received06/23/2022 Decision Date09/14/2022 Product Code NIQ  Advisory Committee Cardiovascular Supplement Typereal-time Process Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No	XIENCE Alpine Everolimus Eluting Coronary Stent System, XIENCE Sierra Everolimus Eluting Coronary Stent System, XIENCE S	2022-09-14